Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis.1982;125:8-15.
Cave MD, Eisenach KD, McDermott PF, Bates JH, Crawford JT. IS6110: conservation of sequence in the Mycobacterium tuberculosis complex and its utilization
in DNA fingerprinting. Mol Cell Probes.1991;5:73-80.
Small PM, Hopewell PC, Singh SP.
et al. The epidemiology of tuberculosis in San Francisco: a population-based
study using conventional and molecular methods. N Engl J Med.1994;330:1703-1709.
Alland D, Kalkut GE, Moss AR.
et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting
and conventional epidemiologic methods. N Engl J Med.1994;330:1710-1716.
Burman WJ, Reves RR, Hawkes AP.
et al. DNA fingerprinting with two probes decreases clustering of Mycobacterium tuberculosis. Am J Respir Crit Care Med.1997;155:1140-1146.
Braden CR, Templeton GL, Cave MD.
et al. Interpretation of restriction fragment length polymorphism analysis
of Mycobacterium tuberculosis isolates from a state
with a large rural population. J Infect Dis.1997;175:1446-1452.
Centers for Disease Control and Prevention. Tuberculosis morbidity—United States, 1997. MMWR Morb Mortal Wkly Rep.1998;47:253-257.
Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City—turning the tide. N Engl J Med.1995;333:229-233.
American Thoracic Society. Treatment of tuberculosis and tuberculous infection in adults and children. Am J Respir Crit Care Med.1994;149:1359-1374.
Chaulk CP, Moore-Rice K, Rizzo R, Chaisson RE. Eleven years of community-based directly observed therapy for tuberculosis. JAMA.1995;274:945-951.
Weis SE, Slocum PC, Blais FX.
et al. The effect of directly observed therapy on the rates of drug resistance
and relapse in tuberculosis. N Engl J Med.1994;330:1179-1184.
Fujiwara PI, Larkin C, Frieden TR. Directly observed therapy in New York City: history, implementation,
results, and challenges. Clin Chest Med.1997;18:135-148.
Centers for Disease Control and Prevention. Screening for tuberculosis and tuberculous infection in high-risk populations,
and the use of preventive therapy for tuberculous infection in the United
States. MMWR Morb Mortal Wkly Rep.1990;39(RR-8):1-12.
Chaulk CP, Pope DS. The Baltimore City Health Department program of directly observed therapy
for tuberculosis. Clin Chest Med.1997;18:149-154.
van Embden JD, Cave MD, Crawford JT.
et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol.1993;31:406-409.
Ross BC, Raios K, Jackson K, Dwyer B. Molecular cloning of a highly repeated DNA element from Mycobacterium tuberculosis and its use as an epidemiological tool. J Clin Microbiol.1992;30:942-946.
Yang Z, Chaves F, Barnes PF.
et al. Evaluation of method for secondary DNA typing of Mycobacterium tuberculosis with pTBN12 in epidemiologic study of tuberculosis. J Clin Microbiol.1996;34:3044-3048.
Michele TM, Cronin WA, Graham NMH.
et al. Transmission of Mycobacterium tuberculosis
by a fiberoptic bronchoscope: identification by DNA fingerprinting. JAMA.1997;278:1093-1095.
Altman DG. Practical Statistics for Medical Research. London, England: Chapman & Hall; 1991.
Cuzick J, Edwards R. Spatial clustering for inhomogeneous populations. J R Stat Soc Ser B.1990;52:73-104.
Simes RJ. An improved Bonferroni procedure for multiple test of significance. Biometrika.1986;73:751-754.
Bishai WR, Graham NMH, Harrington S.
et al. Rifampin-resistant tuberculosis in a patient receiving rifabutin prophylaxis. N Engl J Med.1996;334:1573-1576.
Chaves F, Yang Z, El-Hajj H.
et al. Usefulness of the secondary probe pTBN12 in DNA fingerprinting of Mycobacterium tuberculosis. J Clin Microbiol.1996;34:1118-1123.
Yang ZH, Mtoni I, Chonde M.
et al. DNA fingerprinting and phenotyping of Mycobacterium
tuberculosis isolated from human immunodeficiency virus (HIV)-seropositive
and HIV-seronegative patients in Tanzania. J Clin Microbiol.1995;33:1064-1069.
Blower SM, McLean AR, Porco TC, Hopewell PC, Sanchez MA, Moss AR. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med.1995;1:815-821.
Braden CR. Current concepts in Mycobacterium tuberculosis
DNA fingerprinting. Infect Dis Clin Pract.1997;6:89-95.
van Soolingen D, de Haas PE, Herman PW, Groenen PM, van Embden JD. Comparison of various repetitive DNA elements as genetic markers for
strain differentiation and epidemiology of Mycobacterium
tuberculosis. J Clin Microbiol.1993;31:1987-1995.
Barnes P, El-Hajj H, Preston-Martin S.
et al. Transmission of tuberculosis among the urban homeless. JAMA.1996;275:305-307.
Barnes PF, Yang Z, Preston-Martin S.
et al. Patterns of tuberculosis transmission in central Los Angeles. JAMA.1997;278:1159-1163.
Hermans PW, Messadi F, Guebrexabher H.
et al. Analysis of the population structure of Mycobacterium
tuberculosis in Ethiopia, Tunisia, and the Netherlands: usefulness
of DNA typing for global tuberculosis epidemiology. J Infect Dis.1995;171:1504-1513.
Genewein A, Telenti A, Bernasconi C.
et al. Molecular approach to identifying route of transmission of tuberculosis
in the community. Lancet.1993;342:841-844.
Blower SM, Small PM, Hopewell PC. Control strategies for tuberculosis epidemics: new models for old problems. Science.1996;273:497-500.
Etkind S, Boutotte J, Ford J, Singleton L, Nardell EA. Treating hard-to-treat tuberculosis patients in Massachusetts. Semin Respir Infect.1991;6:273-282.